Revisiting Deterrence: Legal Knowledge, Use Context and Arrest Perception for Cannabis

a1_Deterrence research has evolved considerably since the 1970s when a favourite offence for study was the emerging phenomenon of widespread cannabis use among mainstream populations. The deterrent model of crime prevention has expanded far beyond the study of objective and subjective indicators of certainty and severity to encompass social support, moral evaluations, peer involvement and, most recently, risk sensitivity and situational factors. Most earlier research found no evidence of deterrence of cannabis use, a fi nding attributed to its low actual and perceived risk of arrest and changes in public attitudes. This interview study with adult experienced cannabis users drawn from a representative survey base in Toronto, Canada, where possession is still treated as a criminal offence, provides a more nuanced interpretation of deterrence. The authors found that users had generally inaccurate knowledge about the current law and penalties and believed they would avoid arrest in the future. However, they were not oblivious to the possibility of police intervention, and took precautions such as carrying small amounts and avoiding public use. Thus, users were not unaffected by the law, but rather these discreet practices illustrate the operation of restrictive deterrence, shaping their choices of when, where and how to commit the crime of cannabis use. Further research on deterrence should examine situated choices by risk-sensitive offenders, and should also include cross-national patterns of arrest and user risk perceptions. While cannabis continues to be prohibited by international treaties, the reality of widespread use presents opportunities for innovative deterrence studies into this normalised yet illegal crime.a2_The variation in policies, penalty structures and enforcement across European nations, compared to those in other Western jurisdictions, can foster relevant research for a transatlantic discussion about global drug policy transformation.42744

Illicit opioid use and treatment: Challenges for Canada and beyond (Editorial)

The article discusses various reports published within the issue, including one by Benedikt Fischer about the contemporary phenomenon of illicit opioid use and another by Wim van den Brink and Christian Haasen about the summary of the treatment options for opioid dependence

Sex differences in the endocrine system in response to protein intake early in life

Background: Nutritional factors during a sensitive period can influence child development in a sex-related manner. Objective: Our aim was to investigate whether sex modulates the responses of relevant biochemical parameters and growth to different protein intakes early in life. Design: In a randomized controlled trial, formula-fed infants were assigned to receive formula with higher protein (HP) or lower protein (LP) content. The main outcome measures were insulin-like growth factor (IGF)-1 axis parameters, weight, length, BMI, leptin, and C-peptide/creatinine ratio at 6 mo of age. Dietary intake during the first 6 mo of life was also assessed. Results: The IGF-1 axis response to HP feeding was modulated by sex. Total and free IGF-1 and IGF binding protein 3 concentrations were higher in girls than in boys. Compared with the LP diet, the HP diet was associated with higher IGF-1 and lower IGF binding protein 2 secretion. The response to this HP content formula tended to be stronger in girls than in boys. The HP diet was associated with a higher C-peptide/creatinine ratio. The leptin concentration was higher in girls than in boys and was correlated to the IGF-1 axis parameters. No interaction between sex and nutritional intervention was shown on growth. Conclusions: Our findings show that the endocrine response to a high protein diet early in life may be modulated by sex. The IGF-1 axis of female infants shows a stronger response to the nutritional intervention than does that of male infants, but there is no enhanced effect on growth. This trial was registered at clinicaltrials. gov as NCT00338689. © 2011 American Society for Nutrition.SCOPUS: cp.jinfo:eu-repo/semantics/publishe